Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer (NYSE:PFE) recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at ...

The North America Osteoporosis Treatment Market is experiencing robust growth, anticipated to achieve a CAGR of 7.5% from 2022 to 2028, as per a comprehensive study by Report Ocean, a leading ...

The contributors were recognised by Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of Department of Health – Abu ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

Abu Dhabi, United Arab Emirates – A groundbreaking ‘Declaration on Longevity and Precision Medicine’ was launched at Abu ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel Services & Solutions (OSS) is at the forefront of transforming how Pfizer ...

Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...

Pfizer is committed to advancing scientific research and healthcare initiatives that enhance patient outcomes. Through strategic partnerships and grant programs, Pfizer supports innovation that ...